Logo image of NYAX

NAYAX LTD (NYAX) Stock Fundamental Analysis

USA - NASDAQ:NYAX - IL0011751166 - Common Stock

39.72 USD
-0.73 (-1.8%)
Last: 11/11/2025, 3:02:44 PM
Fundamental Rating

5

Taking everything into account, NYAX scores 5 out of 10 in our fundamental rating. NYAX was compared to 123 industry peers in the Electronic Equipment, Instruments & Components industry. NYAX has only an average score on both its financial health and profitability. NYAX is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one!


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

NYAX had positive earnings in the past year.
NYAX had a positive operating cash flow in the past year.
In the past 5 years NYAX always reported negative net income.
The reported operating cash flow has been mixed in the past 5 years: NYAX reported negative operating cash flow in multiple years.
NYAX Yearly Net Income VS EBIT VS OCF VS FCFNYAX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

1.2 Ratios

NYAX has a Return On Assets of 3.34%. This is in the better half of the industry: NYAX outperforms 61.79% of its industry peers.
NYAX has a better Return On Equity (10.49%) than 73.98% of its industry peers.
NYAX has a Return On Invested Capital of 5.07%. This is comparable to the rest of the industry: NYAX outperforms 57.72% of its industry peers.
Industry RankSector Rank
ROA 3.34%
ROE 10.49%
ROIC 5.07%
ROA(3y)-7.49%
ROA(5y)-8.14%
ROE(3y)-18.51%
ROE(5y)-24.87%
ROIC(3y)N/A
ROIC(5y)N/A
NYAX Yearly ROA, ROE, ROICNYAX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 -10 -20 -30 -40 -50

1.3 Margins

The Profit Margin of NYAX (6.06%) is better than 69.92% of its industry peers.
With a decent Operating Margin value of 6.92%, NYAX is doing good in the industry, outperforming 69.11% of the companies in the same industry.
NYAX has a Gross Margin of 47.33%. This is amongst the best in the industry. NYAX outperforms 81.30% of its industry peers.
In the last couple of years the Gross Margin of NYAX has grown nicely.
Industry RankSector Rank
OM 6.92%
PM (TTM) 6.06%
GM 47.33%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.69%
GM growth 5Y1.55%
NYAX Yearly Profit, Operating, Gross MarginsNYAX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

4

2. Health

2.1 Basic Checks

NYAX has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for NYAX has been increased compared to 1 year ago.
NYAX has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, NYAX has an improved debt to assets ratio.
NYAX Yearly Shares OutstandingNYAX Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 10M 20M 30M
NYAX Yearly Total Debt VS Total AssetsNYAX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

An Altman-Z score of 3.01 indicates that NYAX is not in any danger for bankruptcy at the moment.
NYAX has a Altman-Z score (3.01) which is comparable to the rest of the industry.
NYAX has a debt to FCF ratio of 5.69. This is a neutral value as NYAX would need 5.69 years to pay back of all of its debts.
NYAX's Debt to FCF ratio of 5.69 is in line compared to the rest of the industry. NYAX outperforms 59.35% of its industry peers.
NYAX has a Debt/Equity ratio of 0.84. This is a neutral value indicating NYAX is somewhat dependend on debt financing.
NYAX has a worse Debt to Equity ratio (0.84) than 86.18% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.84
Debt/FCF 5.69
Altman-Z 3.01
ROIC/WACC0.59
WACC8.59%
NYAX Yearly LT Debt VS Equity VS FCFNYAX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

A Current Ratio of 1.68 indicates that NYAX should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.68, NYAX is doing worse than 67.48% of the companies in the same industry.
NYAX has a Quick Ratio of 1.59. This is a normal value and indicates that NYAX is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of NYAX (1.59) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.68
Quick Ratio 1.59
NYAX Yearly Current Assets VS Current LiabilitesNYAX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 196.90% over the past year.
The Revenue has grown by 33.34% in the past year. This is a very strong growth!
The Revenue has been growing by 37.61% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)196.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%471.08%
Revenue 1Y (TTM)33.34%
Revenue growth 3Y38.14%
Revenue growth 5Y37.61%
Sales Q2Q%22.41%

3.2 Future

The Earnings Per Share is expected to grow by 118.54% on average over the next years. This is a very strong growth
Based on estimates for the next years, NYAX will show a very strong growth in Revenue. The Revenue will grow by 23.57% on average per year.
EPS Next Y767.41%
EPS Next 2Y210.64%
EPS Next 3Y118.54%
EPS Next 5YN/A
Revenue Next Year27.97%
Revenue Next 2Y25.38%
Revenue Next 3Y23.57%
Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
NYAX Yearly Revenue VS EstimatesNYAX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M
NYAX Yearly EPS VS EstimatesNYAX Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5 1

4

4. Valuation

4.1 Price/Earnings Ratio

NYAX is valuated quite expensively with a Price/Earnings ratio of 96.88.
NYAX's Price/Earnings is on the same level as the industry average.
NYAX is valuated expensively when we compare the Price/Earnings ratio to 26.28, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 32.05, NYAX can be considered very expensive at the moment.
NYAX's Price/Forward Earnings is on the same level as the industry average.
NYAX is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 33.61, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 96.88
Fwd PE 32.05
NYAX Price Earnings VS Forward Price EarningsNYAX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

NYAX's Enterprise Value to EBITDA ratio is in line with the industry average.
Based on the Price/Free Cash Flow ratio, NYAX is valued a bit cheaper than the industry average as 62.60% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 46.4
EV/EBITDA 31.1
NYAX Per share dataNYAX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as NYAX's earnings are expected to grow with 118.54% in the coming years.
PEG (NY)0.13
PEG (5Y)N/A
EPS Next 2Y210.64%
EPS Next 3Y118.54%

0

5. Dividend

5.1 Amount

No dividends for NYAX!.
Industry RankSector Rank
Dividend Yield N/A

NAYAX LTD

NASDAQ:NYAX (11/11/2025, 3:02:44 PM)

39.72

-0.73 (-1.8%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)08-13 2025-08-13/dmh
Earnings (Next)11-19 2025-11-19/bmo
Inst Owners18.49%
Inst Owner Change7.93%
Ins Owners61.02%
Ins Owner ChangeN/A
Market Cap1.45B
Revenue(TTM)348.66M
Net Income(TTM)21.15M
Analysts84.44
Price Target0.56 (-98.59%)
Short Float %0.11%
Short Ratio1.83
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)85.66%
Min EPS beat(2)-46.52%
Max EPS beat(2)217.85%
EPS beat(4)2
Avg EPS beat(4)35.32%
Min EPS beat(4)-46.52%
Max EPS beat(4)217.85%
EPS beat(8)3
Avg EPS beat(8)-109.01%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-6.14%
Min Revenue beat(2)-7.09%
Max Revenue beat(2)-5.2%
Revenue beat(4)0
Avg Revenue beat(4)-6.31%
Min Revenue beat(4)-7.58%
Max Revenue beat(4)-5.2%
Revenue beat(8)0
Avg Revenue beat(8)-5.58%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)3.54%
PT rev (3m)-5.66%
EPS NQ rev (1m)0%
EPS NQ rev (3m)28.57%
EPS NY rev (1m)0%
EPS NY rev (3m)100%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.36%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.03%
Valuation
Industry RankSector Rank
PE 96.88
Fwd PE 32.05
P/S 4.17
P/FCF 46.4
P/OCF 30.42
P/B 7.22
P/tB 39.53
EV/EBITDA 31.1
EPS(TTM)0.41
EY1.03%
EPS(NY)1.24
Fwd EY3.12%
FCF(TTM)0.86
FCFY2.16%
OCF(TTM)1.31
OCFY3.29%
SpS9.52
BVpS5.5
TBVpS1
PEG (NY)0.13
PEG (5Y)N/A
Graham Number7.13
Profitability
Industry RankSector Rank
ROA 3.34%
ROE 10.49%
ROCE 6.48%
ROIC 5.07%
ROICexc 9.4%
ROICexgc 50.13%
OM 6.92%
PM (TTM) 6.06%
GM 47.33%
FCFM 8.99%
ROA(3y)-7.49%
ROA(5y)-8.14%
ROE(3y)-18.51%
ROE(5y)-24.87%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.69%
GM growth 5Y1.55%
F-Score7
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity 0.84
Debt/FCF 5.69
Debt/EBITDA 3.56
Cap/Depr 69.94%
Cap/Sales 4.72%
Interest Coverage 6.34
Cash Conversion 100.29%
Profit Quality 148.21%
Current Ratio 1.68
Quick Ratio 1.59
Altman-Z 3.01
F-Score7
WACC8.59%
ROIC/WACC0.59
Cap/Depr(3y)12.04%
Cap/Depr(5y)41.15%
Cap/Sales(3y)0.71%
Cap/Sales(5y)2.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)196.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%471.08%
EPS Next Y767.41%
EPS Next 2Y210.64%
EPS Next 3Y118.54%
EPS Next 5YN/A
Revenue 1Y (TTM)33.34%
Revenue growth 3Y38.14%
Revenue growth 5Y37.61%
Sales Q2Q%22.41%
Revenue Next Year27.97%
Revenue Next 2Y25.38%
Revenue Next 3Y23.57%
Revenue Next 5YN/A
EBIT growth 1Y142.95%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year584.16%
EBIT Next 3Y128.77%
EBIT Next 5YN/A
FCF growth 1Y702.71%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y571.56%
OCF growth 3YN/A
OCF growth 5YN/A

NAYAX LTD / NYAX FAQ

What is the ChartMill fundamental rating of NAYAX LTD (NYAX) stock?

ChartMill assigns a fundamental rating of 5 / 10 to NYAX.


What is the valuation status for NYAX stock?

ChartMill assigns a valuation rating of 4 / 10 to NAYAX LTD (NYAX). This can be considered as Fairly Valued.


Can you provide the profitability details for NAYAX LTD?

NAYAX LTD (NYAX) has a profitability rating of 4 / 10.


How financially healthy is NAYAX LTD?

The financial health rating of NAYAX LTD (NYAX) is 4 / 10.